◆ Market Data --:--
Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...
Customize Items

REVOLUTION MEDICINES, INC.

CIK: 1628171 SIC: 2836
-
Revenue
$-1.13B
Net Income
-
Gross Margin
-
Op. Margin
$-1.54B
Free Cash Flow
Financial Statements Quarterly (10-Q)
Showing 13 of 18 quarterly reports available
Breakdown Q4 2025
(Dec 31, 2025)
Q3 2025
(Sep 30, 2025)
Q2 2025
(Jun 30, 2025)
Q1 2025
(Mar 31, 2025)
Q4 2024
(Dec 31, 2024)
Q3 2024
(Sep 30, 2024)
Q2 2024
(Jun 30, 2024)
Q1 2024
(Mar 31, 2024)
Q4 2023
(Dec 31, 2023)
Q3 2023
(Sep 30, 2023)
Q1 2023
(Jun 30, 2023)
Q4 2022
(Dec 31, 2022)
Q3 2022
(Sep 30, 2022)
+ Total Revenue - - - - - - - - $742.00K - $7.01M $15.33M $3.36M
Revenue Growth % (YoY) nan% nan% nan% nan% -100.0% nan% nan% -100.0% -95.2% -100.0% nan% nan% nan%
Operating Expenses $361.63M $315.27M $264.71M $240.76M $216.31M $175.71M $156.64M $140.86M $180.72M $123.25M $82.17M $77.04M $79.89M
Research & Development $294.94M $262.51M $224.13M $205.75M $188.10M $151.75M $134.93M $118.02M $148.48M $107.73M $68.95M $66.13M $69.45M
+ Operating Income $-361.63M $-315.27M $-264.71M $-240.76M $-216.31M $-175.71M $-156.64M $-140.86M $-179.98M $-123.25M $-75.16M $-61.71M $-76.53M
Operating Margin % nan% nan% nan% nan% nan% nan% nan% nan% -24256.5% nan% -1071.5% -402.5% -2280.5%
Interest Expense $11.94M $11.43M - - - - - - - - - - -
Interest Income $21.29M $22.08M $22.40M $24.91M $21.23M $20.41M $21.49M $23.76M $18.98M $10.95M $7.06M $5.08M $2.91M
Other Income/Expense $-3.27M - $16.93M $-10.00K $20.99M $282.00K $16.00K $24.86M $18.79M $10.95M $7.06M $5.08M $2.91M
Income Before Tax $-364.89M $-305.21M $-247.79M $-213.42M $-195.32M $-156.29M $-133.23M $-116.00M $-161.19M $-112.30M $-68.10M $-56.63M $-73.63M
Income Tax Expense - - - - $-753.00K - - - $343.00K $-3.87M - $-123.00K $-297.00K
+ Net Income $-364.89M $-305.21M $-247.79M $-213.42M $-194.57M $-156.29M $-133.23M $-116.00M $-161.54M $-108.43M $-68.10M $-56.51M $-73.33M
Net Margin % nan% nan% nan% nan% nan% nan% nan% nan% -21770.5% nan% -970.9% -368.6% -2185.0%
Basic EPS nan -1.61 -1.31 -1.13 nan -0.94 -0.81 -0.70 nan -0.99 -0.72 nan -0.87
Diluted EPS nan -1.61 -1.31 -1.13 nan -0.94 -0.81 -0.70 nan -0.99 -0.72 nan -0.87
Basic Shares Outstanding - 189.2M 188.6M 188.1M - 166.8M 165.1M 164.7M - 109.2M 94.8M - 84.7M
Diluted Shares Outstanding - 189.2M 188.6M 188.1M - 166.8M 165.1M 164.7M - 109.2M 94.8M - 84.7M
Breakdown Q4 2025
(Dec 31, 2025)
Q3 2025
(Sep 30, 2025)
Q2 2025
(Jun 30, 2025)
Q1 2025
(Mar 31, 2025)
Q4 2024
(Dec 31, 2024)
Q3 2024
(Sep 30, 2024)
Q2 2024
(Jun 30, 2024)
Q1 2024
(Mar 31, 2024)
Q4 2023
(Dec 31, 2023)
Q3 2023
(Sep 30, 2023)
Q1 2023
(Jun 30, 2023)
Q4 2022
(Dec 31, 2022)
Q3 2022
(Sep 30, 2022)
Cash & Cash Equivalents $383.75M $217.44M $402.44M $333.55M $543.06M $201.26M $275.71M $288.43M $696.15M $358.40M $427.22M $161.41M $178.94M
Short-term Investments $1.64B $1.71B $1.73B $1.77B $1.75B $1.35B $1.32B $1.42B $1.16B $454.80M $482.58M $483.53M $476.07M
Other Current Assets $49.36M $45.98M $39.27M $31.91M $38.33M $29.66M $34.02M $25.66M $25.07M $10.96M $8.96M $10.57M $15.15M
Total Current Assets $2.08B $1.98B $2.18B $2.13B $2.33B $1.58B $1.62B $1.73B $1.88B $824.47M $922.75M $660.18M $675.11M
Property Plant & Equipment $33.19M $32.93M $33.05M $27.15M $24.29M $24.81M $25.28M $23.70M $22.86M $20.29M $18.54M $18.66M $18.27M
Goodwill $14.61M $14.61M $14.61M $14.61M $14.61M $14.61M $14.61M $14.61M $14.61M $14.61M $14.61M $14.61M $14.61M
Intangible Assets $55.80M $55.87M $56.14M $56.40M $56.67M $56.94M $57.20M $57.47M $57.74M $58.01M $58.54M $58.81M $59.08M
Other Non-current Assets $14.78M $14.87M $31.42M $13.13M $13.87M $10.28M $8.27M $4.16M $7.03M $11.35M $2.77M $2.86M $856.00K
Total Assets $2.35B $2.25B $2.43B $2.37B $2.56B $1.76B $1.81B $1.91B $2.06B $984.23M $1.07B $811.93M $825.91M
Accounts Payable $64.62M $74.85M $56.76M $47.51M $54.43M $24.46M $29.32M $32.38M $61.79M $29.63M $19.91M $21.31M $24.38M
Accrued Liabilities $5.00M - - - - - - - - - - - -
Deferred Revenue - - - - - - - - - - $1.43M $4.46M $9.69M
Other Current Liabilities $7.86M - - - $583.00K - - - - - - - -
Total Current Liabilities $290.42M $245.62M $184.53M $158.60M $163.91M $110.86M $105.33M $93.72M $143.85M $85.54M $54.63M $61.98M $73.27M
Deferred Tax Liabilities $2.35M $2.35M $2.35M $2.35M $2.35M $3.12M $3.12M $3.12M $3.12M $3.16M $7.03M $7.03M $7.15M
Other Non-current Liabilities $1.21M $2.48M $7.20M $4.14M $670.00K $1.64M $656.00K $3.04M $1.46M $982.00K $1.69M $301.00K $471.00K
Total Liabilities $723.21M $655.02M $564.20M $287.20M $293.10M $196.69M $189.59M $182.90M $235.51M $146.77M $121.03M $126.74M $144.49M
Common Stock $19.00K $18.00K $18.00K $18.00K $18.00K $16.00K $16.00K $16.00K $16.00K $11.00K $11.00K $9.00K $9.00K
Retained Earnings $-2.87B $-2.50B $-2.20B $-1.95B $-1.74B $-1.54B $-1.39B $-1.25B $-1.14B $-976.17M $-769.44M $-701.34M $-644.83M
Total Stockholders Equity $1.63B $1.60B $1.87B $2.08B $2.27B $1.57B $1.62B $1.73B $1.83B $837.46M $952.22M $685.19M $681.42M
Total Liabilities & Equity $2.35B $2.25B $2.43B $2.37B $2.56B $1.76B $1.81B $1.91B $2.06B $984.23M $1.07B $811.93M $825.91M
Breakdown Q4 2025
(Dec 31, 2025)
Q3 2025
(Sep 30, 2025)
Q2 2025
(Jun 30, 2025)
Q1 2025
(Mar 31, 2025)
Q4 2024
(Dec 31, 2024)
Q3 2024
(Sep 30, 2024)
Q2 2024
(Jun 30, 2024)
Q1 2024
(Mar 31, 2024)
Q4 2023
(Dec 31, 2023)
Q3 2023
(Sep 30, 2023)
Q1 2023
(Jun 30, 2023)
Q4 2022
(Dec 31, 2022)
Q3 2022
(Sep 30, 2022)
Net Income $-364.89M $-305.21M $-461.20M $-213.42M $-194.57M $-156.29M $-249.24M $-116.00M $-161.54M $-274.83M $-68.10M $-56.51M $-73.33M
Depreciation & Amortization - - - - - - - - - - $1.21M $1.15M $2.82M
Stock-based Compensation $33.70M $84.69M $53.91M $25.08M $22.44M $56.76M $35.98M $16.21M $25.43M $36.34M $9.70M $8.32M $22.88M
Change in Receivables - - - - - $-1.25M $-1.25M $-1.25M $945.00K $-4.36M $-678.00K $-267.00K $-989.00K
Change in Payables $-10.50M $20.04M $491.00K $-8.27M $29.36M $-35.83M $-33.04M $-28.96M $24.30M $8.16M $-1.05M $-1.51M $8.79M
Operating Cash Flow $-274.24M $-623.50M $-416.19M $-194.44M $-138.29M $-419.15M $-288.73M $-160.56M $-120.56M $-230.01M $-62.39M $-61.79M $-162.61M
Capital Expenditure $1.93M $14.06M $10.72M $3.27M $1.22M $9.09M $5.57M $3.17M $2.32M $5.41M $1.76M $2.88M $7.94M
Purchases of Investments $296.49M $1.50B $1.04B $510.04M $695.21M $1.44B $1.08B $701.68M $519.61M $539.31M $193.10M $160.34M $452.43M
Investing Cash Flow $74.88M $43.18M $18.33M $-15.95M $-392.90M $-161.49M $-140.02M $-247.97M $-380.40M $37.80M $4.00M $-7.10M $-17.01M
Stock Issued - - - - $727.62M - - - - $323.71M $323.71M - $248.13M
Financing Cash Flow $365.66M $255.87M $257.46M $874.00K $873.80M $85.61M $8.31M $810.00K $839.35M $389.85M $324.20M $51.36M $250.07M
Net Change in Cash $166.30M $-324.46M $-140.41M $-209.51M $342.61M $-495.03M $-420.44M $-407.72M $338.39M $197.64M $265.81M $-17.53M $70.44M
SEC Filing Format - Data shown as it appears in the Q3 2025 (10-Q) filing Period ended: Sep 30, 2025
Condensed Consolidated Statements of Operations
Description Sep 30, 2025 Sep 30, 2025
Current Prior Year Current YTD Prior Year YTD
Operating Expenses $315.27M - $820.74M -
Research & Development $262.51M - $692.39M -
Operating Income $-315.27M - $-820.74M -
Interest Expense $11.43M - $12.29M -
Interest Income $22.08M - $69.40M -
Other Income/Expense - - $-42.00K -
Income Before Tax $-305.21M - $-766.41M -
Net Income $-305.21M $-133.23M $-766.41M -
Basic EPS -1.61 - -4.06 -
Diluted EPS -1.61 - -4.06 -
Basic Shares Outstanding $189.23M - $188.66M -
Diluted Shares Outstanding $189.23M - $188.66M -
Condensed Consolidated Balance Sheets
Description Sep 30, 2025 Dec 31, 2024
Cash & Cash Equivalents $217.44M $543.06M
Short-term Investments $1.71B $1.75B
Other Current Assets $45.98M $38.33M
Total Current Assets $1.98B $2.33B
Property Plant & Equipment $32.93M $24.29M
Goodwill $14.61M $14.61M
Intangible Assets $55.87M $56.67M
Other Non-current Assets $14.87M $1.74M
Total Assets $2.25B $2.56B
Accounts Payable $74.85M $54.43M
Total Current Liabilities $245.62M $163.91M
Deferred Tax Liabilities $2.35M $2.35M
Other Non-current Liabilities $2.48M $670.00K
Total Liabilities $655.02M $293.10M
Common Stock $18.00K $18.00K
Retained Earnings $-2.50B $-1.74B
Total Stockholders Equity $1.60B $2.27B
Total Liabilities & Equity $2.25B $2.56B
Condensed Consolidated Statements of Cash Flows
Description Sep 30, 2025 Sep 30, 2025
Current Prior Year Current YTD Prior Year YTD
Net Income $-305.21M $-133.23M $-766.41M -
Stock-based Compensation - - $84.69M -
Change in Receivables - - - -
Change in Payables - - $20.04M -
Operating Cash Flow - - $-623.50M -
Capital Expenditure - - $14.06M -
Purchases of Investments - - $1.50B -
Investing Cash Flow - - $43.18M -
Financing Cash Flow - - $255.87M -
Net Change in Cash - - $-324.46M -

All values are in USD (United States Dollars). Data is sourced from SEC EDGAR 10-Q filings.

Quarterly data represents single quarter results (Q1-Q4). Some items may show year-to-date values if quarterly breakdown is unavailable.

NEWS
Loading article...
NEWS
Loading news...
TRENDING
Loading...